Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Sees Significant Drop in Short Interest

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a significant drop in short interest during the month of February. As of February 27th, there was short interest totaling 5,366 shares, a drop of 65.0% from the February 12th total of 15,313 shares. Based on an average trading volume of 20,956 shares, the short-interest ratio is currently 0.3 days. Currently, 0.1% of the shares of the company are sold short. Currently, 0.1% of the shares of the company are sold short. Based on an average trading volume of 20,956 shares, the short-interest ratio is currently 0.3 days.

Invesco Pharmaceuticals ETF Stock Down 2.6%

NYSEARCA PJP traded down $2.72 on Thursday, hitting $102.74. The stock had a trading volume of 4,156 shares, compared to its average volume of 48,237. Invesco Pharmaceuticals ETF has a one year low of $72.25 and a one year high of $110.81. The stock has a market cap of $392.47 million, a price-to-earnings ratio of 15.59 and a beta of 0.50. The company’s 50-day moving average is $106.76 and its two-hundred day moving average is $101.21.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Equitable Holdings Inc. grew its position in Invesco Pharmaceuticals ETF by 6.2% in the fourth quarter. Equitable Holdings Inc. now owns 3,735 shares of the company’s stock worth $390,000 after acquiring an additional 219 shares in the last quarter. Mariner LLC grew its holdings in Invesco Pharmaceuticals ETF by 18.1% in the 4th quarter. Mariner LLC now owns 3,239 shares of the company’s stock valued at $339,000 after buying an additional 497 shares during the last quarter. Kestra Advisory Services LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF in the fourth quarter worth $192,000. Wells Fargo & Company MN increased its holdings in shares of Invesco Pharmaceuticals ETF by 96.8% during the 4th quarter. Wells Fargo & Company MN now owns 37,772 shares of the company’s stock worth $3,949,000 after purchasing an additional 18,576 shares during the period. Finally, Commonwealth Equity Services LLC raised its holdings in Invesco Pharmaceuticals ETF by 6.3% in the 4th quarter. Commonwealth Equity Services LLC now owns 10,747 shares of the company’s stock valued at $1,124,000 after acquiring an additional 635 shares in the last quarter.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.